Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1557, 2006-01, pp. : 9-10
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Fondaparinux has the edge over enoxaparin in ACS
Inpharma, Vol. 1, Iss. 1505, 2005-01 ,pp. :
Enoxaparin sodium more effective, less costly than UFH
Inpharma, Vol. 1, Iss. 1363, 2002-01 ,pp. :
Enoxaparin sodium more effective, less costly than UFH
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 388, 2002-01 ,pp. :
Enoxaparin dominates UFH for acute coronary syndromes in Poland
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 419, 2003-01 ,pp. :
Use enoxaparin and UFH with caution in renal insufficiency
Inpharma, Vol. 1, Iss. 1435, 2004-01 ,pp. :